Osprey Pharmaceuticals ospreypharma.com


Public lists: Pharma Startups (6570)

Osprey Pharmaceuticals is a privately held biotechnology company focused on developing and commercializing a first-in-class family of therapeutic proteins (Leukocyte Population Modulators) capable of treating chronic diseases. Osprey's broad technology platform is based on the critical insight that many common diseases are propagated by overabundant and overactive leukocytes. The company's proprietary LPMs selectively and systematically destroy disease-related leukocytes by infiltrating the che...Show all

Osprey Pharmaceuticals is a privately held biotechnology company focused on developing and commercializing a first-in-class family of therapeutic proteins (Leukocyte Population Modulators) capable of treating chronic diseases. Osprey's broad technol...Show all

Company (Alive / Active)

Phone: 415-352-6262

Fax:

425 California Street
Suite 1300
San Francisco, 94104
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Osprey Pharmaceuticals $14.8M May 21, 2009
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Osprey Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

VLST Corporation

Seattle, Washington, United States
Assets PurchasedVLST (Viral Logic Systems Technology) has developed a streamlined and efficient platform that rapidly yields biological therapeutic compositions of matter with a far greater likelihood of success in clinical trials, particularly in autoimmune and inflammatory disorders. The VLST approach combines bioinformatics and proteomics to provide a rapid and rational approach to identifying new targets for the development of biologic therapies. Moreover, the process used to identify targets also provides ...Show allLogin to see details

ARC Pharmaceuticals

British Columbia, Canada
Alive / ActiveARC Pharmaceuticals Inc. is a privately owned biotechnology company developing medical products for the treatment of proliferative diseases. The Company holds exclusive intellectual property related to the treatment of surgical adhesions, rheumatoid arthritis, osteoarthritis and psoriasis. ARC's initial focus is on the prevention of surgical adhesion disease, a major complication in a high proportion of common surgical procedures causing pain and dysfunction in millions of patients worldwide.Login to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)